Metraipolis › archive › dc_e604e14c8ed5

Reversal of third-degree AV block with ruxolitinib in VEXAS-associated myocarditis: a case report — Europe PMC PMID:41503257

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41503257
DOI
10.1093/ehjcr/ytaf580
License (as archived)
solo-consultazione
Archived
2026-11-08T16:02:09.205Z
SHA-256 of the archived text
e88c681d7d2254e0e0ec8a4883da87ed19e03c7f139ca7955ae61df0c4eee71a
Stable URL of this page
https://metraipolis.com/documento/dc_e604e14c8ed5

How to cite

Reversal of third-degree AV block with ruxolitinib in VEXAS-associated myocarditis: a case report — Europe PMC PMID:41503257 — Europe PMC (en), https://europepmc.org/article/MED/41503257 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e604e14c8ed5 (Metraipolis archive dc_e604e14c8ed5, sha256 e88c681d7d2254e0e0ec8a4883da87ed19e03c7f139ca7955ae61df0c4eee71a)
BibTeX
@misc{dce604e14c8ed5,
  title = {Reversal of third-degree AV block with ruxolitinib in VEXAS-associated myocarditis: a case report — Europe PMC PMID:41503257},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41503257},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e604e14c8ed5; sha256 e88c681d7d2254e0e0ec8a4883da87ed19e03c7f139ca7955ae61df0c4eee71a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41503257. Agents can read the archived copy with the MCP tool read_document.